Laura Shawver

Companies

• Silverback TherapeuticsBoard member Dec 3, 2020 to now¹
• Relay TherapeuticsBoard member Jul 15, 2020 to Jun 5, 2024²
• Silverback TherapeuticsChief executive officer Dec 3, 2020 to Aug 9, 2022¹
• Nkarta Therapeutics (United States)Board member Jul 9, 2020 to Jun 10, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Silverback Therapeutics SPRY210,346 shares⁴$901.3K at $4.29Apr 7, 2025
• RTRelay Therapeutics RLAY40,000 shares⁵$683.0K at $17.07May 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 7, 2025Sold 50,002 shares at $12.30 of Silverback Therapeutics⁴
• Apr 7, 2025Exercised options 27,493 shares at $4.85 of Silverback Therapeutics⁴
• Apr 7, 2025Exercised options 22,509 shares at $4.85 of Silverback Therapeutics⁴
• Mar 6, 2025Sold 49,600 shares at $11.21 of Silverback Therapeutics⁶
• Mar 6, 2025Exercised options 49,600 shares at $4.85 of Silverback Therapeutics⁶
• Mar 5, 2025Sold 400 shares at $11.00 of Silverback Therapeutics⁶
• Mar 5, 2025Exercised options 400 shares at $4.85 of Silverback Therapeutics⁶
• Feb 3, 2025Sold 50,000 shares at $12.31 of Silverback Therapeutics⁷
• Feb 3, 2025Exercised options 40,936 shares at $4.85 of Silverback Therapeutics⁷
• Feb 3, 2025Exercised options 9,064 shares at $3.15 of Silverback Therapeutics⁷
• Jan 6, 2025Sold 50,000 shares at $11.10 of Silverback Therapeutics⁸
• Jan 6, 2025Exercised options 50,000 shares at $3.15 of Silverback Therapeutics⁸
• Dec 4, 2024Sold 14,772 shares at $13.75 of Silverback Therapeutics⁹
• Dec 4, 2024Exercised options 14,772 shares at $3.15 of Silverback Therapeutics⁹
• Dec 3, 2024Sold 87,984 shares at $13.26 of Silverback Therapeutics⁹
• Dec 3, 2024Exercised options 62,378 shares at $3.15 of Silverback Therapeutics⁹
• Dec 3, 2024Exercised options 25,606 shares at $1.27 of Silverback Therapeutics⁹
• Dec 2, 2024Sold 901 shares at $14.34 of Silverback Therapeutics⁹
• Dec 2, 2024Sold 96,343 shares at $13.55 of Silverback Therapeutics⁹
• Dec 2, 2024Exercised options 29,628 shares at $1.27 of Silverback Therapeutics⁹
• Dec 2, 2024Exercised options 67,616 shares at $1.27 of Silverback Therapeutics⁹
• Sep 1, 2023Sold 100,000 shares at $7.71 of Silverback Therapeutics¹⁰
• Sep 1, 2023Exercised options 97,003 shares at $1.27 of Silverback Therapeutics¹⁰
• Sep 1, 2023Exercised options 2,997 shares at $1.27 of Silverback Therapeutics¹⁰
• Aug 4, 2023Sold 18,897 shares at $7.06 of Silverback Therapeutics¹¹